Latest Advisory

  • FDA Advisory No. 2017-252 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 62)

    FDA Advisory No. 2017-252 || Public Health Warning Against the Use of Unnotified Cosmetic Products (Batch 62)

    Read more

  • FDA Advisory No. 2017-236 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 12)

    FDA Advisory No. 2017-236 || Public Health Warning Against the Use of Unregistered Household/Urban Pesticide Products (Batch 12)

    Read more

  • FDA Advisory No. 2017-253 || Re-certification of Contraceptive Products Pursuant to the Resolution of the Supreme Court dated 25 April 2017 on the Omnibus Motion filed by the Food and Drug Administration on 10 October 2016 in Alliance for the Family Found

    FDA Advisory No. 2017-253 || Re-certification of Contraceptive Products Pursuant to the Resolution of the Supreme Court dated 25 April 2017 on the Omnibus Motion filed by the Food and Drug Administration on 10 October 2016 in Alliance for the Family Found

    Read more

  • PUBLIC SERVICE ANNOUNCEMENT PO MULA SA FOOD AND DRUG ADMINISTRATION

    PUBLIC SERVICE ANNOUNCEMENT PO MULA SA FOOD AND DRUG ADMINISTRATION

    Read more

  • MARCHING ORDERS

    MARCHING ORDERS

    Read more

  • FDA Advisory No. 2017-251 || Voluntary Recall of QIAamp DSP Virus Kit  CE

    FDA Advisory No. 2017-251 || Voluntary Recall of QIAamp DSP Virus Kit CE

    Read more

  • FDA Advisory No. 2017-244 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements and Food Products:

    FDA Advisory No. 2017-244 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements and Food Products:

    Read more

  • FDA Advisory No. 2017-243-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Pekeng Bersyon ng Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    FDA Advisory No. 2017-243-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Pekeng Bersyon ng Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    Read more

  • FDA Advisory No. 2017-243 || Public Health Warning Against the Purchase and Use of the Counterfeit Version of Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    FDA Advisory No. 2017-243 || Public Health Warning Against the Purchase and Use of the Counterfeit Version of Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    Read more

  • FDA Advisory No. 2017-242-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Hindi Rehistradong Gamot na:

    FDA Advisory No. 2017-242-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2017-242 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2017-242 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

    Read more

  • FDA sets first regulatory fair on Aug. 17-18 at PICC

    FDA sets first regulatory fair on Aug. 17-18 at PICC

    Read more

  • FDA holds first regulatory exhibit

    FDA holds first regulatory exhibit

    Read more

  • A ‘new’ FDA

    A ‘new’ FDA

    Read more

  • FDA Advisory No. 2017-250 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplement:

    FDA Advisory No. 2017-250 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplement:

    Read more

  • FDA Advisory No. 2017-249 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2017-249 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    Read more

  • FDA Advisory No. 2017-247 || Public Health Warning Against Unapproved  Advertisement and Promotion of Unregistered V-MORINGA Capsule  with Therapeutic Claims

    FDA Advisory No. 2017-247 || Public Health Warning Against Unapproved Advertisement and Promotion of Unregistered V-MORINGA Capsule with Therapeutic Claims

    Read more

  • FDA Advisory No. 2017-246 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    FDA Advisory No. 2017-246 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    Read more

  • FDA Advisory No. 2017-245 || Public Health Warning Against the following Unregistered Food Supplements with their Corresponding Unapproved and Misleading Advertisements and Promotion:

    FDA Advisory No. 2017-245 || Public Health Warning Against the following Unregistered Food Supplements with their Corresponding Unapproved and Misleading Advertisements and Promotion:

    Read more

  • FDA Advisory No. 2017-241 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2017-241 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    Read more

Additional Instruction for Letters, Commercial Samples, and Approved Labels for Post-Marketing Surveillance (PMS) Purposes to be Submitted to the Center for Drug Regulation and Research

Consistent with the issuance of FDA Memorandum dated 14 august 2014 regarding the Receiving of Product Application and Letter, and to facilitate the processing of related services and regulatory processes, all concerned stakeholders are requested to comply with the following additional instructions:

- For letters, kindly provide contact details (e.g. telephone number(s) and/or e-mail address(es). This will allow online viewing of the letter vial DocTrack at http://www.fda.gov.ph/doctrack-status-know-the-status-of-your-application and minimize the need for the follow-up on the part of the stakeholder.

- For labels submitted as part of post-approval commitment, kindly include copies of the labeling materials as corrected by CDRR. This will facilitate the review and filling of the process of FDA.

- For commercial samples submitted as part of post-approval commitment, kindly include copies of the approved labeling material(s). This will facilitate the review and filling process of FDA.

As part of transparency and rendering faster processing of the above mentioned submissions, instead of issuing acknowledgement letters, FDA shall acknowledgement via DocTrack.

For your information and compliance

Attachments:
Download this file (announcement.pdf)announcement.pdf

 

Announcement

BAC ADVISORY NO. 2014-002
(ITB No. 14-019)

Construction of FDA Walkway, Waiting Shed, Steel Gate and Perimeter Fence

Subject : Re-Scheduled of PRE-BID CONFERENCE

09 December 2014

The PRE-BID CONFERENCE for the above subject project was not transpired on 08 December 2014 due to TYPHOON RUBY that caused work cancellation of all government offices in the National Capital Region (NCR).

In view thereof, all prospective bidders advised that the PRE-BID CONFERENCE is hereby re-scheduled on 11 December 2014 at 2:00pm, AFO Conference Room

For information and guidance of all concerned.

ANNOUNCEMENT

Application for Registration of Raw Materials and Low Risk Pre-Packaged Processed Food Products

In accordance with FDA Circular No. 2014-0029 entitled "Procedure for the Use of Electronic Registration (E-Registration) System for Raw Materials or Ingredients and Low Risk Pre-packaged Processed Food Products," all low risk food products as listed in Annex A of attached AO2014-0029 and raw materials shall be applied online through electronic registration. Following the said circular, the Public Assistance Information and Receiving (PAIR) Unit shall no longer receive application for the raw materials and low risk food products.

For information and guidance

Attachments:
Download this file (ANNOUNCEMENT.pdf)ANNOUNCEMENT.pdf

Procurement and Delivery of One (1) Year Locked in Period and shall be Deemed Renewed until Terminated for Consumable Supply with (50) Units Complimentary Free Use of Printers 4 in 1 Monochrome

SUBJECT : Temporary Suspension of Procurement for ITB 14-017

This is to inform all prospective bidders that the Procurement and Delivery of One (1) Year Locked in Period and Shall be Deemed Renewed until Terminated for Consumables Supply with Fifty (50) Units Complimentary Free Use of Printers 4 in 1 Monochrome (ITB 14-017) is still undergoing review of technical specification and clarification of other requirements thus the aforementioned Project is indefinitely suspended until further notice


Thank You..

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter